CymitQuimica logo

CAS 207395-85-5

:

N-[N-(4-Carboxybutyryl)-4(R)-hydroxy-L-prolyl-L-alanyl-L-seryl-L-cyclohexylglycyl-L-glutaminyl-L-seryl-L-leucyl]doxorubicin

Description:
N-[N-(4-Carboxybutyryl)-4(R)-hydroxy-L-prolyl-L-alanyl-L-seryl-L-cyclohexylglycyl-L-glutaminyl-L-seryl-L-leucyl]doxorubicin, with CAS number 207395-85-5, is a complex synthetic compound that combines the well-known chemotherapeutic agent doxorubicin with a peptide moiety. This modification aims to enhance the drug's therapeutic efficacy and reduce its cardiotoxicity, a common side effect associated with doxorubicin. The presence of the carboxybutyryl group and various amino acids in its structure suggests that it may exhibit improved solubility and bioavailability. The peptide components can facilitate targeted delivery to cancer cells, potentially increasing the drug's effectiveness while minimizing damage to healthy tissues. This compound is part of ongoing research in the field of cancer therapy, particularly in the development of more selective and less toxic chemotherapeutic agents. Its unique structure and properties make it a subject of interest for further studies in drug formulation and cancer treatment strategies.
Formula:C65H89N9O25
Synonyms:
  • L-377202
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.